Another highly-expressed lncRNA in thyroid cancer, MALAT1, can activate angiogenesis via increasing fibroblast growth factor 2 (FGF2) expression in tumor-associated macrophages [153]. This evidence concerns the gene FGF2 and thyroid cancer.